A total of 71 Private Equity/Venture Financing deals (pending and completed) were announced in the Healthcare of Germany, in the last twelve months resulting in a total deal value of over $2,433.2 million. In the LTM period, October 2021 turned out to be the most prolific in terms of deal size, with a total deal value of $1,066.6 million, resulting in an average deal value of $133.3 million during that month. On the other hand, the month of February 2022 was the most prolific in terms of deal volume, recording a total of 9 deals, resulting in an average deal value of $14.1 million during that month.
Of the 71 deals, the deal secured between Coatue Management LLC; Dragoneer Investment Group LLC; Third Point Ventures L.P. and N26 Bank GmbH, was the largest Private Equity/Venture Financing deal in the Germany Healthcare sector, which was valued at $900.0 million and was completed on October 18, 2021. The second-largest deal was between Andera Partners; CaaS Capital Management; Casdin Capital LLC; Fidelity Management & Research Company; Life Sciences Partners BV; Qatar Investment Authority; RA Capital Management LP; Sixty Degree Capital Inc; Versant Venture Management LLC and T-Knife GmbH, while the third-largest deal was between Grunderfonds Ruhr; Hadean Ventures AS; High-Tech Grunderfonds Management GmbH; InnoBio 2; Kurma Partners SA; NRW.Bank; Orbimed Advisors LLC; Pontifax Ltd; RA Capital Management LP; Surveyor Capital Ltd and Emergence Therapeutics AG. The Andera Partners; CaaS Capital Management; Casdin Capital LLC; Fidelity Management & Research Company; Life Sciences Partners BV; Qatar Investment Authority; RA Capital Management LP; Sixty Degree Capital Inc; Versant Venture Management LLC-T-Knife GmbH deal and the Grunderfonds Ruhr; Hadean Ventures AS; High-Tech Grunderfonds Management GmbH; InnoBio 2; Kurma Partners SA; NRW.Bank; Orbimed Advisors LLC; Pontifax Ltd; RA Capital Management LP; Surveyor Capital Ltd-Emergence Therapeutics AG deal were valued at $110.0 million and $98.2 million, respectively. The fourth-largest deal was between Hedosophia-Kaia Health Software GmbH valued at $77.2 million, whereas the deal between ATHOS Service GmbH; M Ventures; MIG Capital AG; Sofinnova Partners SAS; Wellington Partners Venture Capital GmbH-iOmx Therapeutics AG valued at $75.5 million was the fifth-largest deal.
Cumulatively, the top five deals amounted to $1,260.9 million and accounted for nearly 51.82% of the total deals (by value) announced during the last twelve months.
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
United States of America
Japan
Ireland
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer
Contact the team or request a demo to find out how our data can drive your business forward